|
Realtime-Estimate
Cboe BZX
20:47:32 19.11.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 0.4010 USD | -1.69% |
|
-8.41% | -74.49% |
| 14:06 | Outlook Therapeutics, Inc. : Piper Sandler bleibt bei seiner Kaufempfehlung | ZM |
| 09.10. | Outlook Therapeutics ernennt Greg DiPasquale zum Chief Commercial Officer | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.69% | -8.41% | -18.24% | -41.59% | -74.49% | -79.43% | -95.42% | -98.69% | -99.93% | 99.3 Mio. | ||
| +0.19% | -2.90% | +0.06% | -13.63% | +59.30% | +56.40% | +69.15% | +10.22% | - | 65.45 Mrd. | ||
| -0.14% | -3.20% | +17.59% | -2.21% | +19.73% | +7.62% | +90.41% | +238.01% | +6’323.65% | 58.93 Mrd. | ||
| +0.06% | +0.15% | +8.77% | +15.16% | +24.02% | +25.94% | +86.73% | -12.01% | +267.09% | 55.21 Mrd. | ||
| -0.41% | -3.48% | +8.46% | +6.53% | +32.15% | +13.48% | +113.69% | +10.13% | +1’174.14% | 46.1 Mrd. | ||
| -2.37% | -7.14% | -5.31% | +0.99% | +11.69% | +15.76% | +22.64% | -6.12% | +214.62% | 42.49 Mrd. | ||
| +3.61% | +3.86% | +10.82% | +9.97% | +24.72% | +22.82% | +46.39% | +21.63% | +195.61% | 35.56 Mrd. | ||
| -0.10% | -9.16% | -12.05% | -25.37% | +101.14% | +127.14% | +637.25% | +438.50% | - | 34.57 Mrd. | ||
| +0.03% | -0.93% | +37.57% | +62.50% | +72.52% | +76.71% | +57.52% | +27.91% | +180.88% | 32.46 Mrd. | ||
| +20.91% | +22.44% | +51.71% | +10.64% | -16.94% | -28.98% | +487.16% | +374.59% | +888.78% | 26.28 Mrd. | ||
| -1.79% | -10.31% | -9.05% | -9.76% | +39.44% | +37.43% | -7.22% | -60.61% | - | 23.35 Mrd. | ||
| -2.12% | -4.21% | -8.69% | -27.99% | -14.43% | -19.69% | -17.58% | -71.89% | - | 20.64 Mrd. | ||
| -1.55% | -3.17% | +2.64% | +4.57% | +13.25% | +7.41% | +130.48% | +180.19% | +1’669.76% | 18.09 Mrd. | ||
| -5.01% | -3.59% | +11.97% | -0.82% | - | - | - | - | - | 17.73 Mrd. | ||
| -3.39% | -5.46% | +5.34% | +21.40% | +50.65% | +56.69% | +215.48% | +266.22% | +284.57% | 16.66 Mrd. | ||
| -1.23% | -3.41% | +9.73% | +13.52% | +65.03% | +103.66% | +72.78% | -13.34% | +354.45% | 15.97 Mrd. | ||
| +0.71% | -2.61% | +8.51% | +21.23% | +37.28% | +49.23% | +66.65% | -22.28% | +101.51% | 15.93 Mrd. | ||
| -3.21% | -9.74% | -3.21% | -13.93% | +184.40% | +194.75% | +309.77% | +844.81% | +686.93% | 15.64 Mrd. | ||
| -1.84% | -4.49% | +13.89% | +11.02% | +5.09% | +20.58% | -29.08% | -33.09% | +150.62% | 14.62 Mrd. | ||
| -0.52% | -8.10% | -6.64% | -22.21% | +7.60% | -2.90% | +369.41% | - | - | 12.92 Mrd. | ||
| Durchschnitt | +0.06% | -4.67% | +6.20% | +1.00% | +33.80% | +36.03% | +138.22% | +116.34% | +885.19% | 28 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.47% | -3.26% | +8.00% | +3.11% | +38.15% | +38.27% | +137.98% | +107.54% | +1’375.47% |
- Börse
- Aktien
- A4046T Aktie
- Sektor Outlook Therapeutics, Inc.
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen
















